Jacques Bergeron

ORCID: 0000-0003-4540-727X · 1 paper in corpus

article 1988

Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist

Fertility and sterility ·doi:10.1016/s0015-0282(16)59887-2

In order to suppress the pituitary-ovarian axis for treatment of endometriosis, the luteinizing hormone-releasing hormone (LH-RH) agonist buserelin (Hoechst Canada Inc., Montreal, Quebec, Canada) was administered by continuous subcutaneous …